SEC Company Response from Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Oct 10, 2017
Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: Oct. 10, 2017 · CIK: 0001430306 · Accession: 0001615774-17-005663
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220749
Letter
509 Madison Avenue, Suite 306
New York, New York 10022
October 10, 2017
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor, Esq.
Re: Tonix Pharmaceuticals Holding Corp.
Registration Statement on Form S-1
File No. 333-220749
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Tonix Pharmaceuticals Holding Corp. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Thursday, October 12, 2017, or as soon thereafter as possible.
TONIX PHARMACEUTICALS HOLDING CORP.
By: /s/ BRADLEY SAENGER
Name: Bradley Saenger
Title: Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm 509 Madison Avenue, Suite 306 New York, New York 10022 October 10, 2017 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeffrey Gabor, Esq. Re: Tonix Pharmaceuticals Holding Corp. Registration Statement on Form S-1 File No. 333-220749 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Tonix Pharmaceuticals Holding Corp. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Thursday, October 12, 2017, or as soon thereafter as possible. TONIX PHARMACEUTICALS HOLDING CORP. By: /s/ BRADLEY SAENGER Name: Bradley Saenger Title: Chief Financial Officer